Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 471

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 471
---
) 16,250 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

| (8) | Consists of (i) 27,822 shares of common stock held directly by Mr. Giacobello; (ii) 448,270                                                                                                     
 shares issuable upon the exercise of options within 60 days of January 30, 2025; and (iii) 6,750 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

| (9) | Consists of (i) 100,000 shares to be purchased in the PIPE Offering; (ii) 100,000 shares of common stock held 
 directly by Mr. Ball; (iii) 197,943 shares of common stock issuable upon the exercise of options within       |

- 320 -

| 60 days of January 30, 2025 and (iv); 5,000 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025. |

| (10) | Consists of (i) 1,171,543 shares of common stock held indirectly by the Anishka Family Trust, (ii) 639,698                                                                                                                              
 shares of common stock held indirectly by the Anishka Irrevocable 2016 Trust dated October 19, 2016 (the “Anishka Irrevocable Trust”), and (iii) 458,575 shares of common stock issuable upon the exercise of options within 60 days of 
 January 30, 2025. Dr. Desai disclaims beneficial ownership of the securities held in the Anishka Irrevocable Trust, except to the extent of any pecuniary interest therein.                                                             |

| (11) | Consists of (i) 349,761 shares of common stock issuable upon the exercise of options within 60 days of                                                                                                  
 January 30, 2025, (ii) 7,500 shares issuable upon the vesting of restricted stock units within 60 days of January 30, 2025 and (iii) 3,000 shares of common stock held indirectly by Dr. Itri’s spouse. |

| (12) | Consists of (i) 1,666,000 shares to be purchased in the PIPE Offering by KVP Capital, LP (“